E. Garry Menzel - Jun 13, 2023 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Role
Director
Signature
/s/ Stephen Tulipano, Attorney-in-Fact
Stock symbol
STOK
Transactions as of
Jun 13, 2023
Transactions value $
$0
Form type
4
Date filed
6/15/2023, 06:25 PM
Previous filing
Jun 1, 2023
Next filing
Jul 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STOK Director Stock Option (Right to Buy) Award $0 +19.4K $0.00 19.4K Jun 13, 2023 Common Stock 19.4K $12.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall fully vest on June 13, 2024 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.